Cargando…
The Multi Centre Canadian Acellular Dermal Matrix Trial (MCCAT): study protocol for a randomized controlled trial in implant-based breast reconstruction
BACKGROUND: The two-stage tissue expander/implant (TE/I) reconstruction is currently the gold standard method of implant-based immediate breast reconstruction in North America. Recently, however, there have been numerous case series describing the use of one-stage direct to implant reconstruction wi...
Autores principales: | Zhong, Toni, Temple-Oberle, Claire, Hofer, Stefan, Beber, Brett, Semple, John, Brown, Mitchell, Macadam, Sheina, Lennox, Peter, Panzarella, Tony, McCarthy, Colleen, Baxter, Nancy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842809/ https://www.ncbi.nlm.nih.gov/pubmed/24165392 http://dx.doi.org/10.1186/1745-6215-14-356 |
Ejemplares similares
-
Erratum to: The Multi Centre Canadian Acellular Dermal Matrix Trial (MCCAT): study protocol for a randomized controlled trial in implant-based breast reconstruction
por: Zhong, Toni, et al.
Publicado: (2016) -
Canadian Expert Opinion on Breast Reconstruction Access: Strategies to Optimize Care during COVID-19
por: Isaac, Kathryn V., et al.
Publicado: (2022) -
Evaluation of lymphangiogenesis in acellular dermal matrix
por: Cherubino, Mario, et al.
Publicado: (2014) -
Mastopexy: with or without Acellular Dermal Matrix?
por: Abdelkader, Rasha, et al.
Publicado: (2022) -
Clinical and patient reported outcomes in breast reconstruction using acellular dermal matrix
por: Powell-Brett, S., et al.
Publicado: (2018)